News
Global vaccine stocks in focus as the U.S. government plans to phase out investment for mRNA vaccine development activities.
I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.
— Pilot Adrian Eichhorn, a former US military officer, and pilot Shinji Maeda, a native of Japan, who plan to fly in close ...
The federal government is calling off around $500 million worth of vaccine development projects that use mRNA technology, ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results